[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2000265109A1 - Method and compositions for prevention and/or treatment of diabetes and glucose modulation - Google Patents

Method and compositions for prevention and/or treatment of diabetes and glucose modulation

Info

Publication number
AU2000265109A1
AU2000265109A1 AU2000265109A AU6510900A AU2000265109A1 AU 2000265109 A1 AU2000265109 A1 AU 2000265109A1 AU 2000265109 A AU2000265109 A AU 2000265109A AU 6510900 A AU6510900 A AU 6510900A AU 2000265109 A1 AU2000265109 A1 AU 2000265109A1
Authority
AU
Australia
Prior art keywords
diabetes
prevention
compositions
treatment
glucose modulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2000265109A
Inventor
Michael Menard
Susie Rockway
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PharmaNutrients Inc
Original Assignee
PharmaNutrients Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PharmaNutrients Inc filed Critical PharmaNutrients Inc
Publication of AU2000265109A1 publication Critical patent/AU2000265109A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2000265109A 2000-08-02 2000-08-02 Method and compositions for prevention and/or treatment of diabetes and glucose modulation Abandoned AU2000265109A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/021050 WO2002009693A1 (en) 2000-08-02 2000-08-02 Method and compositions for prevention and/or treatment of diabetes and glucose modulation

Publications (1)

Publication Number Publication Date
AU2000265109A1 true AU2000265109A1 (en) 2002-02-13

Family

ID=21741654

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2000265109A Abandoned AU2000265109A1 (en) 2000-08-02 2000-08-02 Method and compositions for prevention and/or treatment of diabetes and glucose modulation

Country Status (4)

Country Link
EP (1) EP1305018A4 (en)
JP (1) JP2004505042A (en)
AU (1) AU2000265109A1 (en)
WO (1) WO2002009693A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001294602A1 (en) 2000-09-21 2002-04-02 Nutrition 21, Inc. Chromium containing compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity and reduction of hyperglycemia and hypercholesteremia
EP1302114A3 (en) * 2001-10-16 2004-01-14 Loders Croklaan B.V. Mixtures for stimulating glucose up-take
DE602004026360D1 (en) * 2004-03-01 2010-05-12 Pharmafrontier Co Ltd PHARMACEUTICAL COMPOSITION FOR REDUCING THE BLOOD SUGAR MIRROR
US7666447B2 (en) 2004-10-08 2010-02-23 Pharmanutrients Compositions including Krill extracts and conjugated linoleic acid and methods of using same
JP5155863B2 (en) 2006-08-11 2013-03-06 花王株式会社 Oil composition
US8809560B2 (en) 2011-05-17 2014-08-19 Board Of Trustees Of The University Of Arkansas Trans-, trans-conjugated linoleic acid compositions and use thereof
ES2395529B1 (en) 2011-06-08 2014-04-11 Pri, S.A. SYNERGIC COMBINATION FOR THE TREATMENT OF MELLITUS DIABETES TYPE 2.
US9897565B1 (en) 2012-09-11 2018-02-20 Aseko, Inc. System and method for optimizing insulin dosages for diabetic subjects
US9171343B1 (en) 2012-09-11 2015-10-27 Aseko, Inc. Means and method for improved glycemic control for diabetic patients
US9062276B2 (en) 2012-12-03 2015-06-23 Board Of Trustees Of The University Of Arkansas Conjugated linoleic acid rich vegetable oil production from linoleic rich oils by heterogeneous catalysis
CN103190611A (en) * 2013-03-17 2013-07-10 王伟 Chrysanthemum capsules with blood sugar reducing function and preparation method thereof
WO2015031089A1 (en) * 2013-08-26 2015-03-05 Liu Charles H Nutraceutical combination for prevention and treatment of type 2 diabetes
US9898585B2 (en) 2014-01-31 2018-02-20 Aseko, Inc. Method and system for insulin management
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
WO2016069475A1 (en) 2014-10-27 2016-05-06 Aseko, Inc. Subcutaneous outpatient management
US11081226B2 (en) 2014-10-27 2021-08-03 Aseko, Inc. Method and controller for administering recommended insulin dosages to a patient
JP6858751B2 (en) 2015-08-20 2021-04-14 アセコー インコーポレイテッド Diabetes Management Therapy Advisor
CN107243043A (en) * 2017-08-17 2017-10-13 刘明州 A kind of Chinese medicine treated diabetes and control its complication to occur

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2053497T3 (en) * 1986-10-27 1994-08-01 Abbott Lab LIQUID NUTRITIONAL FORMULAS FOR GLUCOSE INTOLERANCE.
US5976548A (en) * 1994-11-08 1999-11-02 Viva America Marketing, Inc. Nutritional supplement composition and use
US5730988A (en) * 1995-04-20 1998-03-24 Lynntech, Inc. Nutritional supplements for improving glucose metabolism
CA2280093A1 (en) * 1997-02-04 1998-08-06 John V. Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases
IT1291113B1 (en) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti NUTRITIONAL THERAPEUTIC COMPOSITION FOR SUBJECTS WITH DIABETES MELLITUS
CA2313626A1 (en) * 1997-12-12 1999-06-17 Purdue Research Foundation Methods and compositions for treating diabetes
WO2000012080A1 (en) * 1998-09-01 2000-03-09 Amway Corporation Diet composition and method of weight management

Also Published As

Publication number Publication date
WO2002009693A1 (en) 2002-02-07
EP1305018A1 (en) 2003-05-02
JP2004505042A (en) 2004-02-19
EP1305018A4 (en) 2006-08-30

Similar Documents

Publication Publication Date Title
AU2000265109A1 (en) Method and compositions for prevention and/or treatment of diabetes and glucose modulation
AUPR638101A0 (en) Composition and method for treatment of disease
AU2002241228A1 (en) Method and composition for treatment of skeletal dysplasias
AU2003257937A1 (en) Methods and compositions for treatment of dermal conditions
AU2197100A (en) Treatment of tooth surfaces and substance therefor
AU9040098A (en) Compounds and method for the prevention and treatment of diabetic retinopathy
AU6872498A (en) Method and composition for skin treatment
AU1450900A (en) Methods of treatment of type 2 diabetes
AU2000276362A1 (en) Composition for the treatment of diabetes
AU2002231095A1 (en) Method and composition for the treatment of diabetic neuropathy
AU2001286983A1 (en) Method of treatment
WO2001091700A8 (en) Composition and method for enhancing elasticity of tissue
AU7061200A (en) Compositions and method for treatment of acetaminophen intoxication
AU1794801A (en) Method for treatment and prevention of physiological shock
PL348049A1 (en) Pyridinium derivatives for the treatment of diabetic and aging−related vascular complications
AU2432001A (en) Treatment of mental conditions including depression
AU2003231279A1 (en) Prevention and treatment of type 2 diabetes
AU2002327440A1 (en) Treatment of type i diabetes
AU2420101A (en) Method and composition for the treatment of pain
AUPR644301A0 (en) Method and composition for treatment of cancer
AU2001273759A1 (en) Essential oils and chemically related species for the treatment of increased bone resorption
AU2001262177A1 (en) Method of treatment
AU2002230509A1 (en) Devices and methods for treating low blood sugar levels
HUP0203676A3 (en) Pharmaceutical composition and method for treatment of diabetes
AU4598400A (en) Method of treatment